Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 61 | 2024 | 1813 | 7.840 |
Why?
|
Sleep Apnea Syndromes | 20 | 2024 | 944 | 5.360 |
Why?
|
Polysomnography | 46 | 2024 | 1776 | 4.230 |
Why?
|
Snoring | 7 | 2024 | 191 | 2.200 |
Why?
|
Arousal | 16 | 2023 | 1165 | 2.030 |
Why?
|
Continuous Positive Airway Pressure | 19 | 2024 | 546 | 1.970 |
Why?
|
Osteoporotic Fractures | 4 | 2023 | 401 | 1.770 |
Why?
|
Sound Spectrography | 4 | 2012 | 117 | 1.490 |
Why?
|
Sleep | 27 | 2023 | 4623 | 1.400 |
Why?
|
Respiration | 12 | 2022 | 1653 | 1.360 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15165 | 1.220 |
Why?
|
Pharynx | 8 | 2022 | 413 | 1.170 |
Why?
|
Auscultation | 3 | 2012 | 42 | 1.160 |
Why?
|
Atherosclerosis | 7 | 2023 | 3445 | 1.090 |
Why?
|
Heart Rate | 7 | 2023 | 4091 | 1.050 |
Why?
|
Mandibular Advancement | 2 | 2022 | 64 | 1.000 |
Why?
|
Sleep Stages | 3 | 2018 | 686 | 0.810 |
Why?
|
Epiglottis | 3 | 2018 | 79 | 0.800 |
Why?
|
Blood Circulation | 1 | 2020 | 251 | 0.700 |
Why?
|
Sleep, REM | 6 | 2022 | 595 | 0.680 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 271 | 0.670 |
Why?
|
Mandelic Acids | 5 | 2022 | 47 | 0.650 |
Why?
|
Palate | 2 | 2018 | 123 | 0.640 |
Why?
|
Hypertension | 5 | 2024 | 8480 | 0.610 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6487 | 0.600 |
Why?
|
Respiratory Sounds | 4 | 2013 | 696 | 0.540 |
Why?
|
Tongue | 6 | 2023 | 406 | 0.530 |
Why?
|
Automobile Driving | 1 | 2020 | 431 | 0.510 |
Why?
|
Tachycardia | 2 | 2014 | 619 | 0.480 |
Why?
|
Pattern Recognition, Automated | 2 | 2010 | 1005 | 0.460 |
Why?
|
Posture | 3 | 2017 | 958 | 0.450 |
Why?
|
Occlusal Splints | 2 | 2022 | 20 | 0.410 |
Why?
|
Adrenergic Uptake Inhibitors | 4 | 2021 | 189 | 0.410 |
Why?
|
Risk Assessment | 3 | 2023 | 23338 | 0.390 |
Why?
|
Diagnosis, Computer-Assisted | 3 | 2012 | 719 | 0.380 |
Why?
|
Male | 56 | 2024 | 350118 | 0.380 |
Why?
|
Muscle Hypotonia | 2 | 2022 | 165 | 0.370 |
Why?
|
Middle Aged | 45 | 2023 | 213383 | 0.370 |
Why?
|
Acute Coronary Syndrome | 1 | 2023 | 2337 | 0.360 |
Why?
|
Signal Processing, Computer-Assisted | 3 | 2012 | 1534 | 0.340 |
Why?
|
Humans | 83 | 2024 | 744343 | 0.330 |
Why?
|
Diabetes Mellitus | 2 | 2024 | 5751 | 0.310 |
Why?
|
Body Size | 1 | 2011 | 461 | 0.310 |
Why?
|
Pharyngeal Diseases | 2 | 2019 | 133 | 0.300 |
Why?
|
Wakefulness | 7 | 2023 | 1245 | 0.290 |
Why?
|
Cross-Over Studies | 9 | 2024 | 2029 | 0.280 |
Why?
|
Aged | 25 | 2024 | 163280 | 0.280 |
Why?
|
Female | 46 | 2023 | 380194 | 0.270 |
Why?
|
Oxygen | 4 | 2024 | 4189 | 0.260 |
Why?
|
Acetazolamide | 1 | 2024 | 100 | 0.230 |
Why?
|
Electromyography | 5 | 2023 | 1379 | 0.230 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.220 |
Why?
|
Mouth Breathing | 1 | 2022 | 19 | 0.220 |
Why?
|
Parasympatholytics | 2 | 2020 | 91 | 0.220 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.210 |
Why?
|
Electroencephalography | 7 | 2021 | 6150 | 0.200 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 236 | 0.200 |
Why?
|
Prospective Studies | 7 | 2023 | 53288 | 0.190 |
Why?
|
Facial Muscles | 1 | 2022 | 157 | 0.190 |
Why?
|
Muscarinic Antagonists | 1 | 2021 | 137 | 0.190 |
Why?
|
Oximetry | 2 | 2023 | 471 | 0.190 |
Why?
|
Blood Circulation Time | 1 | 2020 | 11 | 0.190 |
Why?
|
Adult | 29 | 2023 | 214055 | 0.190 |
Why?
|
Endoscopy | 4 | 2018 | 1785 | 0.190 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.190 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 361 | 0.180 |
Why?
|
Pressure | 3 | 2019 | 1203 | 0.180 |
Why?
|
Mouth | 1 | 2022 | 374 | 0.170 |
Why?
|
Algorithms | 9 | 2021 | 13881 | 0.170 |
Why?
|
Reproducibility of Results | 6 | 2021 | 19905 | 0.170 |
Why?
|
Exhalation | 2 | 2018 | 167 | 0.170 |
Why?
|
Principal Component Analysis | 2 | 2012 | 940 | 0.160 |
Why?
|
Prolapse | 1 | 2018 | 68 | 0.160 |
Why?
|
Electrooculography | 1 | 2018 | 118 | 0.160 |
Why?
|
Regression Analysis | 3 | 2024 | 6459 | 0.160 |
Why?
|
Lung Compliance | 1 | 2018 | 195 | 0.160 |
Why?
|
Blood Pressure Determination | 1 | 2022 | 634 | 0.160 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2018 | 141 | 0.160 |
Why?
|
Palate, Soft | 1 | 2018 | 96 | 0.160 |
Why?
|
ROC Curve | 2 | 2018 | 3527 | 0.150 |
Why?
|
Oropharynx | 1 | 2018 | 127 | 0.150 |
Why?
|
Trachea | 3 | 2013 | 1076 | 0.150 |
Why?
|
4-Aminopyridine | 1 | 2017 | 81 | 0.150 |
Why?
|
Nipecotic Acids | 1 | 2017 | 38 | 0.150 |
Why?
|
Potassium Channel Blockers | 1 | 2017 | 171 | 0.140 |
Why?
|
Basal Metabolism | 1 | 2017 | 168 | 0.140 |
Why?
|
Desipramine | 1 | 2016 | 184 | 0.140 |
Why?
|
Pharyngeal Muscles | 3 | 2023 | 77 | 0.140 |
Why?
|
Heart Failure | 1 | 2020 | 10900 | 0.140 |
Why?
|
Manitoba | 1 | 2015 | 23 | 0.140 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.130 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2018 | 367 | 0.130 |
Why?
|
Twins, Monozygotic | 1 | 2017 | 458 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2023 | 832 | 0.130 |
Why?
|
Tidal Volume | 1 | 2017 | 490 | 0.130 |
Why?
|
Respiratory System | 1 | 2018 | 557 | 0.130 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 808 | 0.120 |
Why?
|
Body Mass Index | 2 | 2021 | 12720 | 0.120 |
Why?
|
Wavelet Analysis | 1 | 2014 | 57 | 0.120 |
Why?
|
Sensitivity and Specificity | 3 | 2018 | 14722 | 0.120 |
Why?
|
Pulmonary Ventilation | 2 | 2016 | 373 | 0.120 |
Why?
|
Drug Combinations | 1 | 2019 | 1959 | 0.120 |
Why?
|
Hypnotics and Sedatives | 1 | 2021 | 1162 | 0.110 |
Why?
|
Treatment Outcome | 8 | 2022 | 63114 | 0.110 |
Why?
|
Phenotype | 5 | 2022 | 16365 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2021 | 1004 | 0.110 |
Why?
|
Heart | 2 | 2023 | 4467 | 0.110 |
Why?
|
Pilot Projects | 2 | 2022 | 8324 | 0.100 |
Why?
|
Aging | 1 | 2011 | 8664 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1614 | 0.100 |
Why?
|
Oxygen Consumption | 1 | 2017 | 1869 | 0.100 |
Why?
|
Double-Blind Method | 6 | 2021 | 12026 | 0.090 |
Why?
|
Fuzzy Logic | 1 | 2010 | 56 | 0.090 |
Why?
|
Anthropometry | 2 | 2016 | 1350 | 0.090 |
Why?
|
Acoustics | 1 | 2012 | 239 | 0.090 |
Why?
|
United States | 5 | 2020 | 69872 | 0.090 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2019 | 0.090 |
Why?
|
Proportional Hazards Models | 1 | 2023 | 12354 | 0.080 |
Why?
|
Risk Factors | 5 | 2024 | 72290 | 0.080 |
Why?
|
Respiratory Rate | 2 | 2021 | 162 | 0.080 |
Why?
|
Diaphragm | 2 | 2022 | 349 | 0.080 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 25043 | 0.080 |
Why?
|
Drug Therapy, Combination | 3 | 2024 | 6489 | 0.070 |
Why?
|
Young Adult | 6 | 2024 | 56430 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2012 | 6365 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2208 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2023 | 57776 | 0.070 |
Why?
|
Lung | 5 | 2023 | 9856 | 0.070 |
Why?
|
Electrocardiography | 1 | 2018 | 6442 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2011 | 2373 | 0.060 |
Why?
|
Time Factors | 3 | 2021 | 40075 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15076 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2010 | 2715 | 0.060 |
Why?
|
Sex Factors | 2 | 2021 | 10397 | 0.050 |
Why?
|
Nose | 2 | 2018 | 509 | 0.050 |
Why?
|
Sound | 1 | 2024 | 260 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 20947 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 317 | 0.050 |
Why?
|
Patient Positioning | 1 | 2022 | 324 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12261 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2022 | 968 | 0.040 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 1 | 2018 | 20 | 0.040 |
Why?
|
Sex Characteristics | 2 | 2020 | 2585 | 0.040 |
Why?
|
Transcription Factors | 1 | 2018 | 12208 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2023 | 671 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2018 | 137 | 0.040 |
Why?
|
Blood Pressure | 2 | 2024 | 8554 | 0.040 |
Why?
|
Fingers | 1 | 2020 | 513 | 0.040 |
Why?
|
Reaction Time | 1 | 2023 | 2097 | 0.040 |
Why?
|
Actigraphy | 1 | 2020 | 488 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2214 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 845 | 0.030 |
Why?
|
Supine Position | 1 | 2016 | 205 | 0.030 |
Why?
|
Automation | 1 | 2018 | 584 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2023 | 1901 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 502 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12245 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1616 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2018 | 1590 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2017 | 1005 | 0.030 |
Why?
|
Muscle Contraction | 1 | 2018 | 1240 | 0.030 |
Why?
|
ras Proteins | 1 | 2018 | 1060 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2886 | 0.030 |
Why?
|
Models, Biological | 3 | 2013 | 9583 | 0.030 |
Why?
|
Inhalation | 1 | 2012 | 143 | 0.020 |
Why?
|
Biomedical Engineering | 1 | 2012 | 296 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8340 | 0.020 |
Why?
|
Obesity | 2 | 2023 | 12745 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3558 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 816 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5952 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2012 | 686 | 0.020 |
Why?
|
Trans-Activators | 1 | 2018 | 2924 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21746 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2017 | 1916 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2684 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18370 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13408 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4931 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5708 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 20129 | 0.010 |
Why?
|
Adolescent | 1 | 2023 | 85781 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 77449 | 0.010 |
Why?
|
Concepts
(186)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_